Systemic Treatment for Biochemical Recurrence of Localized Prostate Cancer: Do Not EMBARK on When, If the Answer Is How.
(2024) Journal of clinical oncology — Vol. 42, n° 33, p. 3996-3997 (2024)
Files
2024_Tombal_J_Clin_Oncol.pdf
Open Access - Adobe PDF
- 150.73 KB
Details
- Authors
Giannarini, Gianluca 
- Abstract
- TO THE EDITOR : We are surprised by the interpretation of Einstein et al1 of the EMBARK trial and their view on managing biochemical recurrence (BCR) of localized prostate cancer (PCa).2 It misunderstands the message of EMBARK and contains some incorrect information. Hence, a word of caution should be added to that interpretation. [...]
- Affiliations
Citations
Tombal, B., & Giannarini, G. (2024). Systemic Treatment for Biochemical Recurrence of Localized Prostate Cancer: Do Not EMBARK on When, If the Answer Is How. Journal of clinical oncology, 42(33), 3996-3997. https://doi.org/10.1200/JCO.24.01134 (Original work published 2024)